R. Stevens

发表

Increased peripheral expansion of naive CD4+ T cells in vivo after IL-2 treatment of patients with HIV infection

R. Lempicki, J. Metcalf, M. Baseler, 2002, Proceedings of the National Academy of Sciences of the United States of America.

HIV infection suppresses type 1 lymphokine and IL-12 responses to Toxoplasma gondii but fails to inhibit the synthesis of other parasite-induced monokines.

A. Sher, M. Baseler, L. Wahl, 1995, Journal of immunology.

Interleukin-2 Inhibits HIV-1 Replication in Some Human T Cell Lymphotrophic Virus-1-infected Cell Lines via the Induction and Incorporation of APOBEC3G into the Virion*

D. Huang, R. Lempicki, Jun Yang, 2013, The Journal of Biological Chemistry.

Decreased CD127 Expression on T Cells in HIV-1-infected Adults Receiving Antiretroviral Therapy With or Without Intermittent IL-2 Therapy

J. Metcalf, H. Lane, I. Sereti, 2006, Journal of acquired immune deficiency syndromes.

Effects of Lymphocyte Isolation and Timing of Processing on Detection of CD127 Expression on T Cells in Human Immunodeficiency Virus-Infected Patients

J. Metcalf, M. Baseler, H. Lane, 2005, Clinical Diagnostic Laboratory Immunology.

Design of an observational multi-country cohort study to assess immunogenicity of multiple vaccine platforms (InVITE)

G. E. Potter, L. Dodd, R. Dewar, 2022, PloS one.

Induction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patients.

Douglas A. Hosack, R. Lempicki, D. Dimitrov, 2005, The Journal of clinical investigation.

A randomized, double-blinded, placebo-controlled trial of intermittent administration of interleukin-2 and prednisone in subjects infected with human immunodeficiency virus.

J. Metcalf, R. Davey, M. Baseler, 2003, The Journal of infectious diseases.

Delayed sample processing leads to marked decreases in measured plasma IL-7 levels.

I. Sereti, R. Stevens, Sarah W. Read, 2006, Journal of acquired immune deficiency syndromes.

Effects of intermittent interleukin-2 therapy on plasma and tissue human immunodeficiency virus levels and quasi-species expression.

R. Dewar, J. Metcalf, R. Davey, 2000, The Journal of infectious diseases.

Plasma Interleukin-27 (IL-27) Levels Are Not Modulated in Patients with Chronic HIV-1 Infection

R. Dewar, J. Metcalf, M. Baseler, 2014, PloS one.

Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study.

J. Metcalf, R. Davey, M. Baseler, 1995, The New England journal of medicine.

Preferential survival of CD4+ T lymphocytes engineered with anti-human immunodeficiency virus (HIV) genes in HIV-infected individuals.

H Clifford Lane, J. Metcalf, M. Baseler, 2005, Human gene therapy.

Maintenance of Large Numbers of Virus-Specific CD8+ T Cells in HIV-Infected Progressors and Long-Term Nonprogressors

C. Hallahan, S. Migueles, M. Connors, 2000, The Journal of Immunology.

Effects of Delays in Peripheral Blood Processing, Including Cryopreservation, on Detection of CD31 Expression on Naïve CD4 T Cells

M. Proschan, J. Metcalf, M. Baseler, 2008, Clinical and Vaccine Immunology.

Evaluation of a Single-Platform Technology for Lymphocyte Immunophenotyping

Jean A. Roayaei, J. Metcalf, M. Baseler, 2007, Clinical and Vaccine Immunology.

HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies

H. Clifford Lane, Mark Connors, Julia A. Metcalf, 1997, Nature Medicine.

Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection.

J. Metcalf, R. Davey, M. Baseler, 2000, Blood.

The effects of storage temperature on PBMC gene expression

Xueyuan Zhou, R. Lempicki, Jun Yang, 2016, BMC Immunology.

Identification of Dynamically Distinct Subpopulations of T Lymphocytes That Are Differentially Affected by HIV

Richard A. Lempicki, Michael W. Baseler, H. Clifford Lane, 2001, The Journal of experimental medicine.

Interleukin-15 (IL-15) Strongly Correlates with Increasing HIV-1 Viremia and Markers of Inflammation

Brad T. Sherman, B. Sherman, R. Dewar, 2016, PloS one.

Pharmacokinetic modeling of recombinant interleukin‐2 in patients with human immunodeficiency virus infection

J. Metcalf, R. Davey, M. Baseler, 1998, Clinical pharmacology and therapeutics.

CD4 T cell expansions are associated with increased apoptosis rates of T lymphocytes during IL-2 cycles in HIV infected patients

C. Hallahan, J. Metcalf, R. Davey, 2001, AIDS.

Progression of human immunodeficiency virus disease is associated with increasing disruptions within the CD4+ T cell receptor repertoire.

C. Hallahan, M. Baseler, J. Falloon, 1998, The Journal of infectious diseases.

Longitudinal changes in CD4+ T cell antigen receptor diversity and naive/memory cell phenotype during 9 to 26 months of antiretroviral therapy of HIV-infected patients.

C. Hallahan, M. Baseler, Michael A. Polis, 2000, AIDS research and human retroviruses.

Progressors and Long-Term Nonprogressors T Cells in HIV-Infected + Virus-Specific CD 8 Maintenance of Large Numbers of

C. Hallahan, S. Migueles, M. Connors, 2000 .

Evidence for Increased T Cell Turnover and Decreased Thymic Output in HIV Infection1

Daniel C. Douek, Douglas D. Richman, Michael W. Baseler, 2001, The Journal of Immunology.

Differential effects of HIV viral load and CD4 count on proliferation of naive and memory CD4 and CD8 T lymphocytes.

R. Lempicki, J. Adelsberger, J. Kovacs, 2011, Blood.

Interleukin‐2 induced immune effects in human immunodeficiency virus‐infected patients receiving intermittent interleukin‐2 immunotherapy

R. Lempicki, R. Dewar, J. Metcalf, 2001, European journal of immunology.

The effects of storage temperature on PBMC gene expression

Xueyuan Zhou, R. Lempicki, Jun Yang, 2016, BMC Immunology.

Resistance to Replication of Human Immunodeficiency Virus Challenge in SCID-Hu Mice Engrafted with Peripheral Blood Mononuclear Cells of Nonprogressors Is Mediated by CD8+T Cells and Associated with a Proliferative Response to p24 Antigen

C. Hallahan, R. Davey, M. Connors, 2000, Journal of Virology.

Evaluation of the Performance of the Sysmex XT-2000i Hematology Analyzer With Whole Bloods Stored at Room Temperature.

J. Metcalf, M. Baseler, Zonghui Hu, 2009, Laboratory medicine.

Incomplete CD4 T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover.

R. Dersimonian, C. Yoder, J. Metcalf, 2003, Journal of acquired immune deficiency syndromes.

Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients.

R. Lempicki, D. Dimitrov, R. Dewar, 2000, Proceedings of the National Academy of Sciences of the United States of America.

General Immunologic Evaluation of Patients with Human Immunodeficiency Virus Infection

R. Lempicki, J. Metcalf, V. Natarajan, 2006 .

Pharmacokinetics and Pharmacodynamics of Subcutaneous Interleukin‐2 in HIV‐Infected Patients

J. Metcalf, R. Davey, M. Baseler, 1996, Pharmacotherapy.

Decreased Thymic Output in HIV Infection Evidence for Increased T Cell Turnover and

D. Richman, R. Lempicki, S. Little, 2001 .

Differential effects of HIV viral load and CD4 count on proliferation of naive and memory CD4 and CD8 T lymphocytes.

R. Lempicki, J. Adelsberger, M. Di Mascio, 2011, Blood.